{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:29:56Z","timestamp":1753273796939,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T00:00:00Z","timestamp":1621036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00296-021-04872-w","type":"journal-article","created":{"date-parts":[[2021,5,15]],"date-time":"2021-05-15T10:03:06Z","timestamp":1621072986000},"page":"1979-1986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clonal expansion of large granular lymphocytes in patients with spondyloarthritis and psoriatic arthritis treated with TNF\u03b1 inhibitors"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1935-2092","authenticated-orcid":false,"given":"Eva C.","family":"Schwaneck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regina","family":"Renner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Peter","family":"Tony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Geissinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gernert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Fr\u00f6hlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Schmalzing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ottar","family":"Gadeholt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,15]]},"reference":[{"key":"4872_CR1","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","volume":"129","author":"T Lamy","year":"2017","unstructured":"Lamy T, Moignet A, Loughran TP Jr (2017) LGL leukemia: from pathogenesis to treatment. Blood 129:1082\u20131094","journal-title":"Blood"},{"key":"4872_CR2","doi-asserted-by":"publisher","first-page":"169","DOI":"10.7326\/0003-4819-102-2-169","volume":"102","author":"TP Loughran","year":"1985","unstructured":"Loughran TP, Kadin ME, Starkebaum G, Abkowitz JL, Clark EA, Disteche D et al (1985) Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 102:169\u2013175","journal-title":"Ann Intern Med"},{"key":"4872_CR3","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.clml.2012.06.006","volume":"12","author":"B Bockorny","year":"2012","unstructured":"Bockorny B, Dasanu CA (2012) Autoimmune manifestations in large granular lymphocyte leukemia. Clin Lymphoma Myeloma Leuk 12:400\u2013405","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4872_CR4","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1365-2249.1995.tb02271.x","volume":"101","author":"SJ Bowman","year":"1995","unstructured":"Bowman SJ, Bhavnani M, Geddes GC, Corrigall V, Boylston AW, Panayi GS et al (1995) Large granular lymphocyte expansions in patients with Felty\u2019s syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol 101:18\u201324","journal-title":"Clin Exp Immunol"},{"key":"4872_CR5","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00277-012-1649-1","volume":"92","author":"KG Schrenk","year":"2013","unstructured":"Schrenk KG, Krokowski M, Feller AC, Bernhard V, M\u00fcgge L-O, Oelzner P et al (2013) Clonal T-LGL population mimicking leukemia in Felty\u2019s syndrome\u2014part of a continuus spectrum of T-LGL proliferations? Ann Hematol 92:985\u2013987","journal-title":"Ann Hematol"},{"key":"4872_CR6","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.crohns.2010.05.006","volume":"4","author":"A Thai","year":"2010","unstructured":"Thai A, Prindiville T (2010) Hepatosplenic T-cell lymphoma and inflammatory bowel disease. J. Crohns Colitis 4:511\u2013522","journal-title":"J. Crohns Colitis"},{"key":"4872_CR7","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/cei.12331","volume":"177","author":"J Kelsen","year":"2014","unstructured":"Kelsen J, Dige A, Christensen M, D\u2019Amore F, Iversen L (2014) Frequency and clonality of peripheral \u03b3\u03b4 T cells in psoriasis patients receiving anti-tumour necrosis factor-\u03b1 therapy. Clin Exp Immunol 177:142\u2013148","journal-title":"Clin Exp Immunol"},{"key":"4872_CR8","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s12185-019-02682-2","volume":"110","author":"G Alfano","year":"2019","unstructured":"Alfano G, Fontana F, Colaci E, Mori G, Cerami C, Messerotti A et al (2019) T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature. Int J Hematol 110:313","journal-title":"Int J Hematol"},{"key":"4872_CR9","doi-asserted-by":"publisher","first-page":"1914","DOI":"10.1002\/art.40654","volume":"70","author":"EC Schwaneck","year":"2018","unstructured":"Schwaneck EC, Renner R, Junker L, Einsele H, Gadeholt O, Geissinger E et al (2018) Prevalence and characteristics of persistent clonal T cell large granular lymphocyte expansions in rheumatoid arthritis: a comprehensive analysis of 529 patients. Arthritis Rheumatol 70:1914\u20131922.https:\/\/doi.org\/10.1002\/art.40654","journal-title":"Arthritis Rheumatol"},{"issue":"9783","key":"4872_CR10","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","volume":"377","author":"M Dougados","year":"2011","unstructured":"Dougados M, Baeten D (2011) Spondyloarthritis. Lancet 377(9783):2127\u20132137. https:\/\/doi.org\/10.1016\/S0140-6736(11)60071-8","journal-title":"Lancet"},{"key":"4872_CR11","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","volume":"17","author":"JJM van Dongen","year":"2003","unstructured":"van Dongen JJM, Langerak AW, Br\u00fcggemann M, Evans PAS, Hummel M, Lavender FL et al (2003) Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936. Leukemia 17:2257\u20132317","journal-title":"Leukemia"},{"issue":"6","key":"4872_CR12","doi-asserted-by":"publisher","first-page":"e455","DOI":"10.1038\/bcj.2016.59","volume":"5","author":"MV Sha","year":"2016","unstructured":"Sha MV, Hook CC, Call TG, Go RS (2016) A population-based study of large granular lymphocyte leukemia. Blood Cancer J 5(6):e455","journal-title":"Blood Cancer J"},{"key":"4872_CR13","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.3324\/haematol.2009.018481","volume":"95","author":"B Bareau","year":"2009","unstructured":"Bareau B, Rey J, Hamidou M, Donadieu J, Morcet J, Reman O et al (2009) Analysis of a French cohort of patients with large granular lymphocyte leukemia: a report on 229 cases. Haematologica 95:1534\u20131541","journal-title":"Haematologica"},{"key":"4872_CR14","doi-asserted-by":"publisher","first-page":"R55","DOI":"10.1186\/ar2424","volume":"10","author":"M Prochorec-Sobieszek","year":"2008","unstructured":"Prochorec-Sobieszek M, Rymkiewicz G, Makuch-\u0141asica H, Majewski M, Michalak K, Rupi\u0144ski R et al (2008) Characteristics of T-cell large granular lymphocyte proliferations associated with neutropenia and inflammatory arthropathy. Arthritis Res Ther 10:R55","journal-title":"Arthritis Res Ther"},{"key":"4872_CR15","doi-asserted-by":"publisher","first-page":"e000656","DOI":"10.1136\/rmdopen-2018-000656","volume":"4","author":"JF Merola","year":"2018","unstructured":"Merola JF, Espinoza LR, Fleischmann R (2018) Distinguishing rheumatoid arthritis from psoriatic arthritis. RMD Open 4:e000656","journal-title":"RMD Open"},{"issue":"36","key":"4872_CR16","doi-asserted-by":"publisher","first-page":"13139","DOI":"10.1073\/pnas.1409155111","volume":"111","author":"Q Qi","year":"2014","unstructured":"Qi Q, Liu Yi, Cheng Y, Glanville J, Zhang D, Lee J-Y et al (2014) Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci USA 111(36):13139\u201313144","journal-title":"Proc Natl Acad Sci USA"},{"key":"4872_CR17","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/S0962-8924(00)89088-1","volume":"5","author":"P Vandenabeele","year":"1995","unstructured":"Vandenabeele P, Declercq W, Beyaert R, Fiers W (1995) Two tumour necrosis factor receptors: structure and function. Trends Cell Biol 5:392\u2013399","journal-title":"Trends Cell Biol"},{"issue":"416","key":"4872_CR18","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/416345a","volume":"21","author":"X Li","year":"2002","unstructured":"Li X, Yang Y, Ashwell JD (2002) TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2. Nature 21(416):345\u2013347","journal-title":"Nature"},{"key":"4872_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/eji.201040639","volume":"41","author":"YC Twu","year":"2011","unstructured":"Twu YC, Gold MR, Teh HS (2011) TNFR1 delivers pro-survival signals that are required for limiting TNFR2-dependent activation-induced cell death (AICD) in CD8+ T cells. Eur J Immunol 41:335\u2013344","journal-title":"Eur J Immunol"},{"key":"4872_CR20","doi-asserted-by":"publisher","first-page":"3171","DOI":"10.1002\/eji.200939554","volume":"39","author":"S M\u00fcller","year":"2009","unstructured":"M\u00fcller S, Rihs S, Dayer Schneider JM, Paredes BE, Seibold I, Brunner T et al (2009) Soluble TNF-\u03b1 but not transmembrane TNF-\u03b1 sensitizes T cells for enhanced activation-induced cell death. Eur J Immunol 39:3171\u20133180","journal-title":"Eur J Immunol"},{"issue":"8","key":"4872_CR21","doi-asserted-by":"publisher","first-page":"63799","DOI":"10.18632\/oncotarget.19124","volume":"10","author":"M Zhang","year":"2017","unstructured":"Zhang M, Wang J, Jia L, Huang J, He C, Hu F et al (2017) Transmembrane TNF-\u03b1 promotes activation-induced cell death by forward and reverse signaling. Oncotarget 10(8):63799\u201363812","journal-title":"Oncotarget"},{"key":"4872_CR22","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1097\/MOH.0b013e32831c8407","volume":"16","author":"SR Mohan","year":"2009","unstructured":"Mohan SR, Maciejewski JP (2009) Diagnosis and therapy of neutropenia in large granular lymphocyte leukemia. Curr Opin Hematol 16:27\u201334","journal-title":"Curr Opin Hematol"},{"key":"4872_CR23","doi-asserted-by":"publisher","first-page":"3437","DOI":"10.1016\/j.transproceed.2006.10.045","volume":"38","author":"I Sabnani","year":"2006","unstructured":"Sabnani I, Zucker MJ, Tsang P, Palekar S (2006) Clonal T-large granular lymphocyte proliferation in solid organ transplant recipients. Transplantation Proc 38:3437\u20133440","journal-title":"Transplantation Proc"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04872-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-021-04872-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-021-04872-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T10:13:38Z","timestamp":1632996818000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-021-04872-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,15]]},"references-count":23,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["4872"],"URL":"https:\/\/doi.org\/10.1007\/s00296-021-04872-w","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"type":"print","value":"0172-8172"},{"type":"electronic","value":"1437-160X"}],"subject":[],"published":{"date-parts":[[2021,5,15]]},"assertion":[{"value":"28 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ottar Gadeholt has received speaker\u2019s fees, travel grants, research funding, or compensation for consultancies or board memberships from Chugai (>\u2009$10.000), Roche, Lilly, Sanofi, Orgentec, Novartis, Abbvie. Marc Schmalzing have received speaker\u2019s fees, travel grants, research funding, or compensation for consultancies or board memberships from Chugai\/Roche (>\u2009$10,000) and from AbbVie, Actelion, BMS, Celgene, Genzyme, Hexal\/Sandoz, Janssen-Cilag, MSD, Novartis, Pfizer, Sanofi Pasteur, Takeda (Shire), UCB. Eva Schwaneck has received speaker\u2019s fees, travel grants, research funding, or compensation for consultancies or board memberships from Chugai, Takeda (Shire) (>\u2009$10,000 each), Roche, AbbVie, Janssen, Novartis, Lilly. Hans-Peter Tony has received speaker\u2019s fees, travel grants, research funding, or compensation for consultancies or board memberships from AbbVie, Amgen, BMS, Celgene, Chugai, Gilead, Janssen, Lilly, Novartis, Pfizer, Roche, and Sanofi. Michael Gernert received travel grants from AbbVie, Chugai, Hexal, Janssen, Lilly, Pfizer, Roche. Matthias Fr\u00f6hlich received travel grants from AbbVie, Chugai, Janssen, and Roche. Regina Renner, Eva Geissinger and Alexander Weber have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study was approved by the local ethics committee (file number 192\/17-sc).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}]}}